Cargando…

SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas

Meningiomas represent the most frequently diagnosed intracranial tumors. Inflammation and immune processes may play an important role in therapeutic response as well as in anti- and pro-tumor modulating function. In tumors, inflammatory markers have been able to provide useful prognostic information...

Descripción completa

Detalles Bibliográficos
Autores principales: Leães Rech, Carolina Garcia Soares, Minuzzi, Ricardo Kunde, Silva, Camila Batista de Oliveira, Araújo, Bruna, Mafalda, Tainá, Ferreira, Nelson Pires, Oliveira, Miriam da Costa, Pereira-Lima, Júlia F Semmelmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208882/
http://dx.doi.org/10.1210/jendso/bvaa046.553
_version_ 1783530950136692736
author Leães Rech, Carolina Garcia Soares
Minuzzi, Ricardo Kunde
Silva, Camila Batista de Oliveira
Araújo, Bruna
Mafalda, Tainá
Ferreira, Nelson Pires
Oliveira, Miriam da Costa
Pereira-Lima, Júlia F Semmelmann
author_facet Leães Rech, Carolina Garcia Soares
Minuzzi, Ricardo Kunde
Silva, Camila Batista de Oliveira
Araújo, Bruna
Mafalda, Tainá
Ferreira, Nelson Pires
Oliveira, Miriam da Costa
Pereira-Lima, Júlia F Semmelmann
author_sort Leães Rech, Carolina Garcia Soares
collection PubMed
description Meningiomas represent the most frequently diagnosed intracranial tumors. Inflammation and immune processes may play an important role in therapeutic response as well as in anti- and pro-tumor modulating function. In tumors, inflammatory markers have been able to provide useful prognostic information for treatment or clinical evaluation of patients. The aim of this study was to investigate preoperative hematological markers concerning recurrence or regrowth and clinical variables in meningioma. Eighty nine patients with no corticosteroid therapy were included. Blood tests and tumor characteristics were collected from medical records. Recurrence-free survival was evaluated using Cox regression and Kaplan-Meier curves. Of the 89 cases, 73 (82%) were grade I and 16 (18%) grade II. The mean age was 53±13.9 years, with higher frequency in women, 2:1 proportion. The most frequent subtypes were meningothelial (40.4%), transitional (23.5%) and atypical (17.9%), 64% with peripheral location and 64% had a size greater than 3 cm. Regarding tumor resection, 49 (55.1%) underwent complete surgery (40 remained with tumor (81.6%) and 9 relapse (18.3%)) and 40 (44.9%) submitted to partial resection surgery (29 remained with persistent lesion (72.5%) and 11 regrowth (25%)). In total, 20 (22.4%) cases of recurrence or regrowth were observed. The median recurrence-regrowth free survival (RFS) was 62 months, 96.1% at 1 year, 67.4% at 3 years and 51.2% at 5 years. In univariate analysis, anemia (p=0.04), neutrophilia (p=0.02) and neutrophilis/lymphocyts ratio (NLR) (p=0.03) were associated with an increased risk of recurrence or regrowth and poor RFS. In multivariate, the interaction between anemia and NLR >4 represented a higher risk of recurrence or regrowth (p=0.003). The preoperative presence of anemia, neutrophilia, and NLR was associated with an increased risk of recurrence or regrowth in meningiomas, emphasizing the importance of preoperative evaluation of these parameters.
format Online
Article
Text
id pubmed-7208882
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72088822020-05-13 SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas Leães Rech, Carolina Garcia Soares Minuzzi, Ricardo Kunde Silva, Camila Batista de Oliveira Araújo, Bruna Mafalda, Tainá Ferreira, Nelson Pires Oliveira, Miriam da Costa Pereira-Lima, Júlia F Semmelmann J Endocr Soc Tumor Biology Meningiomas represent the most frequently diagnosed intracranial tumors. Inflammation and immune processes may play an important role in therapeutic response as well as in anti- and pro-tumor modulating function. In tumors, inflammatory markers have been able to provide useful prognostic information for treatment or clinical evaluation of patients. The aim of this study was to investigate preoperative hematological markers concerning recurrence or regrowth and clinical variables in meningioma. Eighty nine patients with no corticosteroid therapy were included. Blood tests and tumor characteristics were collected from medical records. Recurrence-free survival was evaluated using Cox regression and Kaplan-Meier curves. Of the 89 cases, 73 (82%) were grade I and 16 (18%) grade II. The mean age was 53±13.9 years, with higher frequency in women, 2:1 proportion. The most frequent subtypes were meningothelial (40.4%), transitional (23.5%) and atypical (17.9%), 64% with peripheral location and 64% had a size greater than 3 cm. Regarding tumor resection, 49 (55.1%) underwent complete surgery (40 remained with tumor (81.6%) and 9 relapse (18.3%)) and 40 (44.9%) submitted to partial resection surgery (29 remained with persistent lesion (72.5%) and 11 regrowth (25%)). In total, 20 (22.4%) cases of recurrence or regrowth were observed. The median recurrence-regrowth free survival (RFS) was 62 months, 96.1% at 1 year, 67.4% at 3 years and 51.2% at 5 years. In univariate analysis, anemia (p=0.04), neutrophilia (p=0.02) and neutrophilis/lymphocyts ratio (NLR) (p=0.03) were associated with an increased risk of recurrence or regrowth and poor RFS. In multivariate, the interaction between anemia and NLR >4 represented a higher risk of recurrence or regrowth (p=0.003). The preoperative presence of anemia, neutrophilia, and NLR was associated with an increased risk of recurrence or regrowth in meningiomas, emphasizing the importance of preoperative evaluation of these parameters. Oxford University Press 2020-05-08 /pmc/articles/PMC7208882/ http://dx.doi.org/10.1210/jendso/bvaa046.553 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Tumor Biology
Leães Rech, Carolina Garcia Soares
Minuzzi, Ricardo Kunde
Silva, Camila Batista de Oliveira
Araújo, Bruna
Mafalda, Tainá
Ferreira, Nelson Pires
Oliveira, Miriam da Costa
Pereira-Lima, Júlia F Semmelmann
SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas
title SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas
title_full SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas
title_fullStr SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas
title_full_unstemmed SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas
title_short SUN-130 Preoperative Hematological Parameters Associated with Recurrence or Regrowth of Meningiomas
title_sort sun-130 preoperative hematological parameters associated with recurrence or regrowth of meningiomas
topic Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208882/
http://dx.doi.org/10.1210/jendso/bvaa046.553
work_keys_str_mv AT leaesrechcarolinagarciasoares sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas
AT minuzziricardokunde sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas
AT silvacamilabatistadeoliveira sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas
AT araujobruna sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas
AT mafaldataina sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas
AT ferreiranelsonpires sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas
AT oliveiramiriamdacosta sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas
AT pereiralimajuliafsemmelmann sun130preoperativehematologicalparametersassociatedwithrecurrenceorregrowthofmeningiomas